Lilly 3977 40 mg (Retevmo 40 mg)
Generic Name: selpercatinib
Pill with imprint Lilly 3977 40 mg is Gray, Capsule-shape and has been identified as Retevmo 40 mg. It is supplied by Eli Lilly and Company.
Retevmo is used in the treatment of non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. Retevmo 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Lilly 3977 40 mg
More about Retevmo (selpercatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: multikinase inhibitors
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.